| Page 1977 | Kisaco Research
 

Bertrand Alexandre

Global Marketing Director
Celyad

Bertrand Alexandre

Global Marketing Director
Celyad

Bertrand Alexandre

Global Marketing Director
Celyad
The Scientist Job Opportunity
 

Andy Wines

Founder & Managing Director
Fuse Brands

Andy Wines

Founder & Managing Director
Fuse Brands

Andy Wines

Founder & Managing Director
Fuse Brands
 

Michael Robinson

Managing Director
Robinson Young

Michael Robinson

Managing Director
Robinson Young

Michael Robinson

Managing Director
Robinson Young
 

Andrew Guise

CEO
Purity Healthcare Ltd

Dr Andrew Guise, CEO Purity Health ltd.  Andrew is an executive with over 20 years experience, advising, investing in and managing businesses across all segments of Healthcare, from drug discovery through to managed care. He is a passionate advocate of Corporate Venture Capital advising Imperial Brands to create Fontem Ventures. Purity Health is licensing patented products to replace pills/capsules with easy and enjoyable to consume alternatives. 

Andrew Guise

CEO
Purity Healthcare Ltd

Andrew Guise

CEO
Purity Healthcare Ltd

Dr Andrew Guise, CEO Purity Health ltd.  Andrew is an executive with over 20 years experience, advising, investing in and managing businesses across all segments of Healthcare, from drug discovery through to managed care. He is a passionate advocate of Corporate Venture Capital advising Imperial Brands to create Fontem Ventures. Purity Health is licensing patented products to replace pills/capsules with easy and enjoyable to consume alternatives. 

 

Richard Brandt

Founder & ECD
BrandtBrand

Richard has been referred to as “the branding industry’s most accomplished creative director”. 

During his 24 years as Landor Associates Executive Creative Director, and 30 years total in the industry, Richard has led all aspects of brand identity programs for Fortune 100 global corporations, the world’s best-known brands, and new-to-world start ups.

Richard Brandt

Founder & ECD
BrandtBrand

Richard Brandt

Founder & ECD
BrandtBrand

Richard has been referred to as “the branding industry’s most accomplished creative director”. 

During his 24 years as Landor Associates Executive Creative Director, and 30 years total in the industry, Richard has led all aspects of brand identity programs for Fortune 100 global corporations, the world’s best-known brands, and new-to-world start ups.

Passionate about all the ways branding can be a business accelerator, Richard has created programs ranging from brand identity and packaging design, naming and corporate B2B branding, as well as retail design. He has a special affinity for hospitality and particularly strong background in innovation (new brand creation).

Richard's was the creator of the "Pepsi Blue" identity, and catapulted multiple Diageo brands to worldwide success, including Smirnoff, Ketel One, Don Julio tequila, and Johnnie Walker. In recognition of his many contributions, Diageo named Richard  “One of the 10 most important people in the life of the Captain Morgan brand”.

Richard as also led programs for KFC, Dean & Deluca, Embraer Jets, and Tiger Woods. He has extensive expertise across categories from luxury goods to Pharma, from OTC to food, and from cosmetics to home goods.

Always believing that the root of success is transferrable, Richard has developed an easily understood set of methodologies and best-practices designed to take consumer brands to the next level, regardless of category.

In 2015 Richard founded BrandtBrand, a strategic branding and design agency based in New York City. In 3 years, BrandtBrand has successfully created new-to-world brands, and repositioned mature brands in the health and wellness space, spirits, housewares and hospitality. Their current client roster includes The Nature’s Bounty Co., Joy Mangano, Old Elk Distilleries and Unicef, among others. 

 
21-22 Mar 2018
Kansas City, USA
The Animal Microbiome Congress USA brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to understand the latest research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering.Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. The conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts. Our ‘MEETING MOJO’ platform will allow you to schedule meetings across the two conference days to facilitate future collaborations and business partnering.